Results 271 to 280 of about 308,033 (340)

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Smoking and smoking cessation among smokers in Saudi Arabia: A cross-sectional study. [PDF]

Tob Induc Dis
Arida H, Alhothali AA, AlOtaibi TH, Almalki ON, Alosaimi AH, Alenazi AT, Al Boqami AA, Eldalo AS, Algarni MA, Althobaiti M, Abdelwahab SF.   +10 more
europepmc   +1 more source

Examining the role of freebase nicotine in the harm reduction potential of oral nicotine pouches versus moist snuff: A randomized crossover trial

Addiction, EarlyView.
Abstract Background and aims Oral nicotine pouches (ONPs) contain varying proportions of freebase nicotine (FBN), with higher FBN expected to increase nicotine delivery across the oral mucosa. Because ONPs contain fewer toxicants than moist snuff and may serve as a reduced harm alternative for smokeless tobacco, we compared how the FBN in ONPs affects ...
Brittney Keller‐Hamilton, Hayley Curran, Leanne Atkinson, Sriya Suraapaneni, Alice Hinton, Kirsten Chrzan, Darren Mays, Ahmad El‐Hellani, Clark W. Wilson, Marielle C. Brinkman, Theodore L. Wagener   +10 more
wiley   +1 more source

Smoking cessation after referral from hospital to community stop smoking services: an observational study. [PDF]

BMJ Public Health
Cherodian R, Franklin M, Baxter S, Chilcott J, Gillespie D.   +4 more
europepmc   +1 more source

Persistence of systemic inflammation in COPD in spite of smoking cessation

, 2019
Giovanni Invernizzi
openalex   +2 more sources

A systematic review of reviews on comprehensive community initiatives to prevent or reduce alcohol and other drug harms

Addiction, EarlyView.
Abstract Background and Aims Comprehensive community initiatives (CCI) aimed at reducing or preventing alcohol or other drug (AOD) harms incorporate multiple initiatives delivered to whole communities to effect community‐level change on sociocultural and environmental factors.
Peter John Gates, Andrea C. Zocco, Sara Farnbach   +2 more
wiley   +1 more source

Nicotine pouches and clinical outcomes related to smoking cessation: A systematic review of randomized trials

Addiction, EarlyView.
Abstract Background and aims Tobacco‐free nicotine pouches (NPs) are oral nicotine products promoted by manufacturers and some researchers as tools that may reduce nicotine cravings and support smoking reduction or cessation. However, evidence regarding their actual clinical impact remains limited.
Javad Heshmati, Spencer Shahen, Emma Lynn Bates, Sarah Visintini, Evyanne Quirouette, Kerri‐Anne Mullen, Hassan Mir   +6 more
wiley   +1 more source

Pilot Study of a Mobile, Virtual Reality-Based Digital Therapeutic for Smoking Cessation: Randomized Controlled Trial.

JMIR Mhealth Uhealth
Jo YS, Pyeon A, Hu MK, Kim S, Choi IY, Kim DJ, Chun JW.   +6 more
europepmc   +1 more source

Understanding the role of cessation fatigue in smoking relapse: Findings from the International Tobacco Control Four Country Smoking and Vaping Survey

Addiction, EarlyView.
Abstract Background and Aim Relapse risk among people who formerly smoke is influenced by task difficulty. Cessation fatigue (CF) may be a better predictor than measures such as reported strength of urges to smoke (SUTS) and abstinence self‐efficacy (ASE). It may also be affected by quit length and use of other nicotine products.
Hua‐Hie Yong, Ron Borland, Michael Le Grande, Claire Chia‐Yu Hu, Coral Gartner, Andrew Hyland, Kenneth Michael Cummings   +6 more
wiley   +1 more source